Key Efficacy Comparison Year 1 Outcomes: For chronic weight management in adults without diabetes, tirzepatide 15 mg achieved a mean 22.5% total body weight reduction in SURMOUNT-1 (N Engl J Med, 2022), while semaglutide 2.4 mg delivered approximately 15% in the STEP program
Initial shipping charges are non-refundable
Label Check : Choose cereals and plant-based meat alternatives with added Iron and B12
The platform strips away the telehealth industry's traditional roadblocks to provide frictionless, equitable access to life-changing treatments
At Pasadena Weight Loss Center, our doctors use both to customize your FIT50 weight loss plan
Its all about helping you find a comfortable, sustainable approach that fits your body, your goals and your lifestyle